Research, Development and Innovation Fund Announces First Cohort of 19 Second Level Fund Managers

1. At a Glance

• The RDI Scheme / RDI Fund (RDIF) has a ₹1 lakh crore corpus. It gives long-term, low-interest "patient capital" to private-sector R&D in sunrise and strategic sectors [1][2].
• It uses a two-tier fund-of-funds design. A Special Purpose Fund within ANRF holds the corpus and does not invest directly. It passes money to Second Level Fund Managers (SLFMs), who finance enterprises [2][6].
• The fund targets a financing gap: private investment in high-risk, high-impact R&D and strategic technologies has historically been low [1].
• It is tied to technological sovereignty, Atmanirbhar Bharat and Viksit Bharat 2047. Expect questions on R&D financing, GERD (gross expenditure on R&D) and private R&D in GS-III [1].

2. Why in the News

• 12 Oct 2026: the RDIF announced its first cohort of 19 SLFMs, made up of 14 Alternative Investment Funds (AIFs) and 5 Focused Research Organisations (FROs). The total RDIF commitment is ₹7,131 crore [1].
• The Empowered Group of Secretaries (EGoS) approved the cohort at its meeting on 08 Oct 2026 [1].
• The EGoS also approved five more technologies for coverage under the RDI Fund [1].

3. Background & Evolution

• Rationale: to turn India "from a technology consumer" into a leading technology provider, and to make up for low private R&D investment in emerging and strategic technologies [1].
• Milestones:
• 01 Jul 2025: Union Cabinet approved the RDI Scheme with a ₹1 lakh crore corpus over six years. It includes support for Deep-Tech Funds of Funds [2].
• Oct 2025: the ANRF Executive Council approved major decisions on operationalising the RDI Fund [3].
• 03 Nov 2025: the Prime Minister formally launched the scheme [4][9].
• Jan 2026: first call for SLFM applications launched. It closed on 31 Jan 2026 [1][6].
• 04 Feb 2026 and 13 Feb 2026: TDB and BIRAC, already designated as SLFMs, launched their own calls for project proposals [6]. TDB's first window funds high-risk technology commercialisation at TRL 4+ [7].
• 2026: Special Financial Rules, 2026 for using the RDI Fund were published in the Gazette [11].
• Jul 2026: Parliament was told that 162 AIF and 38 FRO applications had been received, with a proposed commitment of about ₹8,000 crore, still under consideration. TDB and BIRAC had each been sanctioned ₹1,000 crore as SLFMs [4][5].

• 08–12 Oct 2026: EGoS approved the first cohort of 19 SLFMs and it was announced [1].

• Earlier and related bodies: TDB (under DST) and BIRAC (under DBT) were existing financing bodies. They became the earliest SLFMs [4][6].

4. Core Static Facts

Governance layers [2][9]:

• ANRF Governing Board (chaired by the PM): sets overall strategic direction.
• ANRF Executive Council: approves guidelines and recommends SLFMs and the scope of sunrise-sector projects.
• EGoS (led by the Cabinet Secretary): approves scheme changes, sectors, project types and SLFMs, and reviews performance.
• Selection pipeline for SLFMs: objective assessment of applications → interaction with an Expert Advisory Committee → ANRF Executive Council → EGoS [1].

5. Multi-Dimensional Analysis

Economic

• Patient, risk-tolerant debt and equity aims to pull in private R&D capital that would otherwise stay away [1][5].
• The 1:1 private-mobilisation expectation means the ₹7,131 crore commitment could support roughly twice that amount in total [1].
• Choosing loans over grants means money should flow back into the fund. The trade-off is that very early-stage research gets no support [5].

Scientific / Technological

• The TRL 4+ threshold aims at the gap between lab validation and commercialisation (the "valley of death"). Basic research (TRL 1–3) stays with the ANRF grant channels [1][7].
• Focused Research Organisations (FROs) as SLFMs bring in a mission-driven, non-traditional research-finance model alongside VC-style AIFs [1].
• Science 4 Technology framing: R&D led by industry, not only by academia [1].

Geopolitical / Strategic

• Aims for technological sovereignty and less dependence on imported technologies in strategic areas such as quantum, AI and energy security [1][9].
• Supports Atmanirbhar Bharat in critical and emerging technologies, in line with the goal of becoming a global technology provider [1].

Governance / Administrative

• Approval runs through several layers (Expert Advisory Committee → ANRF Executive Council → EGoS), which is good for accountability but can cause delays. About 200 applications took around 9 months to reach the first approvals [1][4][6].
• Using professional fund managers keeps government out of picking individual firms, but it adds fund-management fees and a principal-agent problem [2][6].
• An Independent Business Unit within ANRF and Special Financial Rules, 2026 give it institutional ring-fencing and financial flexibility [1][11].

6. Recent Developments (last 12–18 months)

• Oct 2025: ANRF Executive Council took the key decisions to operationalise the RDI Fund [3].
• 03 Nov 2025: PM launched the RDI Scheme [4][9].
• Jan 2026: first SLFM call launched and closed on 31 Jan 2026 [1][6]. A separate DST advertisement recruited the RDIF management team, with a deadline of 15 Jan 2026 [12].
• Feb 2026: TDB (04 Feb) and BIRAC (13 Feb) opened project calls [6][7].
• Jul 2026: Parliament was told of 162 AIF and 38 FRO applications (about ₹8,000 crore proposed), and of ₹1,000 crore each sanctioned to TDB and BIRAC [4][5].
• 08 Oct 2026: EGoS approved 19 SLFMs (₹7,131 crore) and five more technologies [1].
• 12 Oct 2026: the first cohort was publicly announced, and more cohorts are planned [1].

7. Prelims Hooks

• RDI Scheme corpus: ₹1 lakh crore over 6 years [2].
• Approved by the Union Cabinet on 1 July 2025. Launched by the PM on 3 November 2025 [2][4].
• Nodal department: Department of Science & Technology (not MeitY, not DBT) [2].
• RDIF is managed by an Independent Business Unit housed within ANRF [1].
• The Special Purpose Fund in ANRF is the first-level custodian and does not invest directly in firms [2][6].
• EGoS is led by the Cabinet Secretary and approves SLFMs and sectors [9].
• ANRF Governing Board is chaired by the Prime Minister [9].
• First SLFM cohort: 19, made up of 14 AIFs + 5 FROs [1].
• First-cohort RDIF commitment: ₹7,131 crore [1].
• Beneficiaries: Eligible Technology Enterprises at TRL 4 and above [1].
• SLFMs must mobilise private capital equal to the RDIF contribution [1].
• Support is long-term low-interest loans / equity, not grants [5].
• Maximum support: 50% of project cost [8].
• TDB and BIRAC were the first designated SLFMs, each sanctioned ₹1,000 crore [4][5].

8. Why ₹7,131 Crore Is a Promise, Not Money Spent

• A 'commitment' is a promise to pay over several years, not cash already given
• The ₹7,131 crore is what RDIF has agreed to put into 19 SLFMs [1].
• SLFMs take the money in parts, only after they find suitable projects. So the money that actually reaches firms will be much smaller at first.

• The exam point: when a scheme reports progress, ask how much was committed and how much was disbursed (actually paid out).

• Even the commitments cover only a small part of the corpus

• ₹1 lakh crore over 6 years works out to about ₹16,700 crore a year on average [2].
• About a year after the launch, committed money is ₹7,131 crore plus ₹1,000 crore each to TDB and BIRAC, roughly ₹9,100 crore in all [1][4].

• That is less than one year's average share, and more cohorts are still to come [1].

• Science money in India has gone unspent before

• In 2023-24 the National Research Foundation (now ANRF) got ₹2,000 crore in the BE (Budget Estimate, the amount planned at the start of the year). This was cut to ₹259 crore in the RE (Revised Estimate, the amount updated later in the year) [13].
• From 2018 to 2024, DST and DBT each spent on average 18% less than their budget estimates [13].
• So a large corpus on paper does not mean the money will be used. Spending speed is the real test of the RDIF.

9. The Real Shortage May Be Researchers, Not Money

• Private R&D in India has stayed low for years
• India's GERD was 0.64% of GDP in 2020-21, and had been falling as a share of GDP since 2009-10 [13].
• Private R&D stayed at about 0.25% of GDP. Private firms were 36% of national R&D spending, and government was 64% [13].

• Countries that spend 2% of GDP or more on R&D get over half of it from private firms [13]. India set this 2% goal in its 2013 STI Policy, and has not come close [13].

• Cheap capital needs good projects to fund

• India had about 260 researchers per million people, against 1,602 in China and 4,452 in the USA [13].
• RDIF funds only TRL 4+ projects, meaning the technology already works in a lab [1]. Fewer researchers means fewer such projects are ready.

• If there are too few strong projects, SLFMs will either sit on unused money or lend to weaker projects.

• Firms that already exist spend little of their own money on R&D

• In 2020-21, private companies spent 1.46% of their sales on R&D, and public sector companies spent 0.3%. Neither number moved much from 2015 to 2021 [13].
• A loan covers at most 50% of the project cost [8]. The firm must still find the other half, so firms that don't value R&D today may not apply.

10. Will Private Investors Really Match the Government?

• The 1:1 rule assumes private money will follow public money
• Each SLFM is expected to bring in private capital equal to the RDIF contribution [1].

• If private investors do not come in, the fund is half its expected size. That is about ₹7,131 crore of lending power lost from this cohort alone.

• The ANRF itself was built on the same assumption

• The ANRF plan was ₹50,000 crore over five years, with ₹36,000 crore expected from non-government sources [13].
• The government side was cut back (₹2,000 crore BE to ₹259 crore RE in 2023-24) [13], and no clear record of private inflow has been published.

• The RDIF is a test of whether this "government money brings private money" idea actually works.

• Applications show demand. The cut shows selectivity

• Parliament was told of 200 applications (162 AIFs and 38 FROs) asking for about ₹8,000 crore [4][5].
• Only 19 were approved, at ₹7,131 crore [1]. Fewer than one in ten applicants got through, but they got most of the money asked for.
• So the money went to a few large managers, not many small ones. Watch whether later cohorts spread the money more widely.

11. The Case Against Lending to Private Firms — and the Answer

• The strongest objection: this may pay firms for what they would do anyway
• Firms that apply for cheap loans are often the ones that already do R&D. The public money then replaces private money instead of adding to it. Economists call this 'deadweight'.
• Critics also say public money should go first to universities. A Parliament Standing Committee (Report 343, 2021) found that most publicly funded research happens in specialised institutes, and universities are left mainly as teaching centres [13].

• Meanwhile, ANRF grant money, which does reach universities, was cut sharply in 2023-24 [13].

• What the objection gets right

• Nothing in the RDIF design measures whether a project is extra R&D or would have happened anyway [1][6].

• Basic research (TRL 1–3) gets nothing from the RDIF [1]. If grant budgets keep being underspent, the gap at the bottom of the research chain grows.

• Why the fund still makes sense

• It lends instead of giving grants [5]. Repaid money returns to the fund, so the real cost to the government is much lower than ₹1 lakh crore.
• The 1:1 private match means firms and investors must risk their own money too [1]. That partly guards against deadweight.

• It targets TRL 4+ [1]. Grants rarely reach this stage, and banks don't lend for it because there are no assets to pledge. That is a real gap.

• Fair conclusion for an answer: the RDIF can work alongside grant funding for basic research. It cannot replace it.

12. What Should Be Done Next

• ANRF and DST should publish disbursement, not just commitment, for each SLFM
• Announcements so far give commitments (₹7,131 crore; ₹1,000 crore each to TDB and BIRAC) [1][4].

• Given the record of BE-to-RE cuts in science budgets [13], Parliament needs yearly data on money actually paid out, firms funded, and private capital actually raised.

• EGoS should judge SLFMs on private money brought in, not on money lent out

• The draft STI Policy 2020 aims to double the private share of GERD within five years [13].

• Tying SLFM reviews to this target keeps the fund focused on its real purpose: more private R&D, not just more lending.

• The Ministry of S&T should protect ANRF grant budgets alongside RDIF

• The Standing Committee (Report 343, 2021) noted the weak research base of universities [13].

• The RDIF needs a steady flow of TRL 4 projects, and those projects start as grant-funded lab work. Cutting grants weakens the RDIF itself.

• Use existing nudges for firms

• Since October 2019, companies can count research contributions as CSR spending [13].
• The government could link this with RDIF projects, so CSR money helps firms put up their share of the project cost.

13. Anchors for Answers

• Data: GERD was 0.64% of GDP in 2020-21 and had been falling as a share of GDP since 2009-10. Private R&D was stuck near 0.25% of GDP, 36% of the national total [13]
• Data: India had about 260 researchers per million people, against 1,602 in China and 4,452 in the USA [13]
• Data: ANRF/NRF allocation in 2023-24 was cut from ₹2,000 crore (BE) to ₹259 crore (RE) [13]
• Report/Committee: Parliamentary Standing Committee on S&T, Environment, Forests and Climate Change, Report 343 (2021): universities have been left mainly as teaching centres [13]. NITI Aayog (2018): low private R&D is "one of the major challenges" [13]
• Comparison: Countries that spend 2% or more of GDP on R&D get over 50% of it from the private sector. India's 2013 STI Policy target of 2% remains far off [13]
• Scheme: ANRF (₹50,000 crore over five years, with ₹36,000 crore expected from non-government sources) is the earlier test of the same "public money brings private money" idea [13]. Draft STI Policy 2020 aims to double the private share of GERD in five years [13]

14. Mains Relevance

• GS-III: Science & Technology (developments and their applications; indigenisation of technology and developing new technology). Indian Economy (mobilisation of resources; investment models).
• GS-II: Government policies and interventions; institutional design (ANRF, EGoS).
• Question stems: 1. India's low private-sector share in R&D spending is a structural constraint on technological sovereignty. Critically examine how the ₹1 lakh crore RDI Fund seeks to address this. (15 marks) 2. Discuss the merits and risks of a fund-of-funds model, using Second Level Fund Managers, for financing deep-tech R&D in India. (10 marks) 3. Patient capital rather than grants: evaluate the shift in India's innovation-financing philosophy under the RDI Scheme. (15 marks)

15. Related Topics to Study Next

• Anusandhan National Research Foundation (ANRF): parent body and its governance structure.
• Technology Development Board (TDB): DST's financing body and one of the first SLFMs.
• BIRAC / BioE3 policy: biotech financing channel and SLFM.
• Deep-Tech Fund of Funds: separately supported under the RDI Scheme. Compare the design.
• SEBI AIF Regulations (Category I/II AIFs): the regulatory vehicle used by 14 of the 19 SLFMs.
• National Quantum Mission / IndiaAI Mission: the sunrise sectors the RDIF is meant to serve.
• Technology Readiness Levels (TRL 1–9): the eligibility threshold, frequently tested.
• GERD and the private share of R&D: background statistics for Mains answers.

16. NCERT Concepts to Revise

• Fund of funds (Economy): RDIF uses a two-tier design: the main fund passes money to Second Level Fund Managers instead of investing directly.
• Principal-agent problem (Economy): The note flags that hiring fund managers to pick firms creates a risk that managers pursue their own interests.
• Deep-tech startup (Economy): RDIF targets high-risk, long-gestation deep-tech such as quantum, AI and biotech, which ordinary lenders avoid funding.
• Investment (Economy): The fund aims to raise private investment in R&D, and the 1:1 private-match rule rests on this idea.
• Capital (Economy): RDIF provides 'patient capital', meaning long-term, low-interest financial capital for firms' research and production.
• Sovereignty (Polity): The scheme is justified by technological sovereignty, meaning less dependence on imported technology in strategic areas.

17. Common Errors / Trap Areas

• Approval vs launch: Cabinet approved it in July 2025, the PM launched it in Nov 2025, and the first SLFM call came in Jan 2026. Do not mix up these years [1][2][4].
• Who chairs what: the PM chairs the ANRF Governing Board, while the Cabinet Secretary leads the EGoS, which approves SLFMs [9].
• Grants vs loans: the RDIF gives no grants, only loans or equity [5].
• Count of SLFMs: "19" refers only to the first cohort selected through the open call. TDB and BIRAC were designated SLFMs separately and earlier, so the total number of SLFMs is higher [1][4][6].
• TRL threshold: it is TRL 4 and above, not TRL 1+ and not TRL 7+. The fund does not support basic research [1].